93 related articles for article (PubMed ID: 16580649)
1. Extended therapeutic time window after focal cerebral ischemia by non-competitive inhibition of AMPA receptors.
Elger B; Gieseler M; Schmuecker O; Schumann I; Seltz A; Huth A
Brain Res; 2006 Apr; 1085(1):189-94. PubMed ID: 16580649
[TBL] [Abstract][Full Text] [Related]
2. FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release.
Shichinohe H; Kuroda S; Abumiya T; Ikeda J; Kobayashi T; Yoshimoto T; Iwasaki Y
Brain Res; 2004 Mar; 1001(1-2):51-9. PubMed ID: 14972653
[TBL] [Abstract][Full Text] [Related]
3. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
[TBL] [Abstract][Full Text] [Related]
5. The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
Erdo F; Berzsenyi P; Andrási F
Brain Res Bull; 2005 Jul; 66(1):43-9. PubMed ID: 15925143
[TBL] [Abstract][Full Text] [Related]
6. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
7. Effects of delayed intrathecal infusion of an NMDA receptor antagonist on ischemic injury and peri-infarct depolarizations.
Lu XC; Williams AJ; Wagstaff JD; Tortella FC; Hartings JA
Brain Res; 2005 Sep; 1056(2):200-8. PubMed ID: 16112094
[TBL] [Abstract][Full Text] [Related]
8. Magnesium sulfate fails to reduce infarct volume following transient focal cerebral ischemia in rats.
Zhu HD; Martin R; Meloni B; Oltvolgyi C; Moore S; Majda B; Knuckey N
Neurosci Res; 2004 Jul; 49(3):347-53. PubMed ID: 15196783
[TBL] [Abstract][Full Text] [Related]
9. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
[TBL] [Abstract][Full Text] [Related]
10. Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.
Elger B; Huth A; Neuhaus R; Ottow E; Schneider H; Seilheimer B; Turski L
J Med Chem; 2005 Jul; 48(14):4618-27. PubMed ID: 15999999
[TBL] [Abstract][Full Text] [Related]
11. Spermine reduces infarction and neurological deficit following a rat model of middle cerebral artery occlusion: a magnetic resonance imaging study.
Shirhan MD; Moochhala SM; Ng PY; Lu J; Ng KC; Teo AL; Yap E; Ng I; Hwang P; Lim T; Sitoh YY; Rumpel H; Jose R; Ling E
Neuroscience; 2004; 124(2):299-304. PubMed ID: 14980380
[TBL] [Abstract][Full Text] [Related]
12. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats.
Sato T; Takamori H; Shirasaki Y
Pharmacology; 2004 May; 71(1):38-45. PubMed ID: 15051921
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
Mauler F; Horváth E
J Cereb Blood Flow Metab; 2005 Apr; 25(4):451-9. PubMed ID: 15674237
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice.
Egashira N; Hayakawa K; Mishima K; Kimura H; Iwasaki K; Fujiwara M
Neurosci Lett; 2004 Jun; 363(1):58-61. PubMed ID: 15157996
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
Zhang Y; Feustel PJ; Kimelberg HK
Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of a novel herbal decoction on focal cerebral ischemia in a rodent model.
Kim MG; Choi JH; Lim JP; Kim DK; Shin TY; Boo Y; Kim SY; Kim H; Ha E; Park HK; Kim J; Lim HS; Kim EH; Kim JB; Leem KH
Neurol Res; 2007; 29 Suppl 1():S16-22. PubMed ID: 17359635
[TBL] [Abstract][Full Text] [Related]
17. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
Vakili A; Zahedi-Khorasani M
Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
[TBL] [Abstract][Full Text] [Related]
18. Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis.
Elger B; Schneider M; Winter E; Carvelli L; Bonomi M; Fracasso C; Guiso G; Colovic M; Caccia S; Mennini T
ChemMedChem; 2006 Oct; 1(10):1142-8. PubMed ID: 16972289
[TBL] [Abstract][Full Text] [Related]
19. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
20. Combined magnesium and mild hypothermia (35 degrees C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h.
Campbell K; Meloni BP; Knuckey NW
Brain Res; 2008 Sep; 1230():258-64. PubMed ID: 18644354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
